Janssen - Johnson & Johnson COVID-19 Vaccine
Generic name: COVID-19 (coronavirus 2019) Vaccine, Janssen - Johnson & Johnson (KOE Vid (koe ROE Na Vye Rus) VAX Een)
Brand names: Janssen COVID-19 Vaccine PF
Drug class:
Viral vaccines
Usage of Janssen - Johnson & Johnson COVID-19 Vaccine
Discontinued. The FDA revoked emergency use authorization (EUA) for the Janssen COVID-19 Vaccine on Thursday, June 1, 2023, after a request from Janssen. The last lots of the vaccine have expired, there is no demand for new lots of the vaccine in the U.S., and the company does not intend to update the strain composition of this vaccine to address emerging variants. This information is kept here for research purposes.The Janssen COVID-19 Vaccine may help your body develop immunity to SARS-CoV-2. However, this vaccine has not been approved to prevent or treat coronavirus or COVID-19 and is no longer available.
The Janssen COVID-19 vaccine is used in people 18 years and older:
COVID-19 is a serious disease caused by a coronavirus called SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). COVID-19 is spread from person to person through the air.
COVID-19 can affect your lungs or other organs. Symptoms may be mild or serious and include fever, chills, cough, sore throat, shortness of breath, tiredness, body aches, headache, loss of taste or smell, runny or stuffy nose, nausea, vomiting, or diarrhea.
The COVID-19 vaccine is used to help prevent severe disease and death from COVID-19 caused by SARS-CoV-2.
COVID-19 vaccine does not contain coronavirus and cannot give you COVID-19. This vaccine will not treat an active COVID-19 infection.
Like any vaccine, Janssen COVID-19 Vaccine may not provide protection in every person.
Janssen - Johnson & Johnson COVID-19 Vaccine side effects
Get emergency medical help if you have signs of an allergic Reaction to Janssen COVID-19 Vaccine: hives; dizziness, weakness, fast heartbeats; difficult breathing; swelling of your face, lips, tongue, or throat.
An allergic reaction is more likely to occur within a few minutes to 1 hour after you receive the vaccine. You will be treated quickly if you have a reaction.
Becoming infected with COVID-19 is much more dangerous to your health than receiving Janssen COVID-19 Vaccine.
Some people HAD blood clots 1 to 2 weeks after receiving Janssen COVID-19 Vaccine, but the risk of this side effect is remote. Seek medical attention right away if you have:
Some people receiving Janssen COVID-19 Vaccine had nervous system problems within 42 days after receiving this vaccine, but the risk of this side effect is very low. Seek medical attention right away if you have:
Capillary leak syndrome is a rare but serious side effect. Call your doctor right away if you have signs of this condition: stuffy or runny nose followed by tiredness, thirst, decreased urination, trouble breathing, and sudden swelling or weight gain.
Not all possible side effects are known.
Common Janssen COVID-19 Vaccine side effects may include:
Other side effects, mild or serious, may occur with more widespread use of COVID-19 vaccine.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.
You may also use a smartphone-based program called V-safe to communicate with the Centers for Disease Control and Prevention (CDC) about any health problems you have after receiving a COVID-19 vaccine.
Before taking Janssen - Johnson & Johnson COVID-19 Vaccine
You should not receive the Janssen COVID-19 vaccine if you had an allergic reaction after a previous dose of this vaccine or if you had a blood clot with a low level of platelets after receiving this vaccine or the AstraZeneca COVID-19 vaccine (not authorized or approved in the United States).
If you are infected with COVID-19, are waiting for testing results, or are exposed to someone infected with COVID-19: You may not be able to receive Janssen COVID-19 Vaccine until you have no symptoms and/or your required quarantine period has ended. Receiving Janssen COVID-19 Vaccine will not make you less contagious to other people if you are infected with COVID-19 but you have no symptoms.
Ask your doctor if you are unsure about any COVID-19 treatments you received.
To make sure Janssen COVID-19 Vaccine is safe for you, tell your doctor if:
COVID-19 is more likely to cause serious illness or death in a pregnant woman. Not all risks are known yet, but Janssen COVID-19 Vaccine is likely to be less harmful than becoming infected with COVID-19 during pregnancy.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of Janssen COVID-19 Vaccine on the baby.
Relate drugs
- Abrysvo
- ACAM2000
- Adenovirus vaccine, live
- Afluria
- Afluria 2015-2016 Formula
- Afluria PF Pediatric Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2022-2023 injection
- Afluria PF Quadrivalent 2023-2024 injection
- Afluria Quadrivalent 2021-2022 injection
- Afluria Quadrivalent 2022-2023 injection
- Afluria Quadrivalent 2023-2024 injection
- Agriflu
- Arexvy
- Attenuvax
- Audenz
- Comirnaty
- Comirnaty (2023-2024) PF (cvx 309) 2023-2024
- COVID-19 (12y+) vaccine Spikevax 2023-2024
- COVID-19 (12y+) vaccine, Pfizer 2023-2024
- COVID-19 (5y-11y) vaccine, Pfizer 2023-2024
- COVID-19 (6m-11y) vaccine, Moderna 2023-2024
- COVID-19 (6m-4y) vaccine, Pfizer 2023-2024
- COVID-19 vaccine, Novavax (2023-2024)
- Mumps virus vaccine, live
- Mumpsvax
- Cervarix
- Dengue tetravalent vaccine, live
- Dengue vaccine
- Dengvaxia
- Dryvax
- Engerix-B
- Engerix-B (HepB)
- Engerix-B Pediatric
- Fluad
- Fluad 2017-2018 Formula
- Fluad Quadrivalent PF 2022-2023 injection
- Fluad Quadrivalent PF 2023-2024 injection
- Fluarix PF Quadrivalent 2021-2022 injection
- Fluarix PF Quadrivalent 2022-2023 injection
- Fluarix PF Quadrivalent 2023-2024 injection
- Fluarix Quadrivalent
- Fluarix Quadrivalent 2013-2014 Formula
- Fluarix Quadrivalent 2015-2016 Formula
- Flublok 2015-2016 Formula
- Flublok 2016-2017 Formula
- Flublok 2017-2018 Formula
- Flublok Quadrivalent
- Flublok Quadrivalent 2016-2017 Formula
- Flublok Quadrivalent 2017-2018 Formula
- Flublok Quadrivalent 2021-2022 injection
- Flublok Quadrivalent 2022-2023 injection
- Flublok Quadrivalent 2023-2024 injection
- Flucelvax 2015-2016 Formula
- Flucelvax PF Quadrivalent 2021-2022 injection
- Flucelvax PF Quadrivalent 2022-2023 injection
- Flucelvax PF Quadrivalent 2023-2024 injection
- Flucelvax Quadrivalent
- Flucelvax Quadrivalent 2021-2022 injection
- Flucelvax Quadrivalent 2022-2023 injection
- Flucelvax Quadrivalent 2023-2024 injection
- FluLaval PF Quadrivalent 2021-2022 injection
- FluLaval PF Quadrivalent 2022-2023 injection
- FluLaval PF Quadrivalent 2023-2024 injection
- Flulaval Quadravalent 2013-2014 Season
- FluLaval Quadrivalent
- FluLaval Quadrivalent 2015-2016 Formula
- Flumist
- FluMist Quadrivalent 2015-2016 Formula
- FluMist Quadrivalent 2023-2024 nasal
- Fluvirin 2015-2016 Formula
- Fluzone 2013-2014 Formula
- Fluzone 2015-2016 Formula
- Fluzone High Dose 2015-2016 Formula
- Fluzone High-Dose Quadrivalent PF 2021-2022 injection
- Fluzone High-Dose Quadrivalent PF 2022-2023 injection
- Fluzone High-Dose Quadrivalent PF 2023-2024 injection
- Fluzone Intradermal Quadrivalent 2014-2015 Formula
- Fluzone Intradermal Quadrivalent 2015-2016 Formula
- Fluzone PF Pediatric Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2022-2023 injection
- Fluzone PF Quadrivalent 2023-2024 injection
- Fluzone Quadrivalent
- Fluzone Quadrivalent 2021-2022 injection
- Fluzone Quadrivalent 2022-2023 injection
- Fluzone Quadrivalent 2023-2024 injection
- Gardasil 9
- Gardasil 9 Vaccine
- Havrix
- Havrix Pediatric
- Hepatitis A adult vaccine
- Hepatitis A pediatric vaccine
- Hepatitis a vaccine
- Hepatitis B adult vaccine
- Hepatitis B pediatric vaccine
- Hepatitis b vaccine
- Hepatitis b vaccine recombinant, adjuvanted
- Heplisav-B
- Human papillomavirus (HPV) vaccine, 9-valent
- Human papillomavirus vaccine
- Imovax Rabies human diploid cell
- Influenza A (H1N1) 2009 Monovalent Vaccine
- Influenza a virus vaccine, h1n1, inactivated
- Influenza a virus vaccine, h5n1, adjuvanted
- Influenza virus vaccine
- Influenza virus vaccine injection
- Influenza virus vaccine nasal
- Influenza virus vaccine recombinant
- Influenza virus vaccine, adjuvanted
- Influenza Virus Vaccine, H5N1
- Influenza virus vaccine, live
- Ipol
- Ixiaro
- Janssen - Johnson & Johnson COVID-19 Vaccine
- Japanese encephalitis virus vaccine SA14-14-2
- Jynneos
- Measles virus vaccine, live
- Meruvax II
- Moderna COVID-19 (2023-2024) PF Vaccine (cvx 311) 2023-2024
- Moderna COVID-19 Vaccine
- Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) 2023-2024
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) 2023-2024
- Pfizer-BioNTech COVID-19 Vaccine
- Polio vaccine, inactivated
- Poliovirus vaccine, inactivated
- PreHevbrio
- RabAvert purified chick embryo cell
- Rabies vaccine human diploid cell
- Rabies vaccine purified chick embryo cell
- Recombivax HB
- Recombivax HB Adult
- Recombivax HB Dialysis Formulation
- Recombivax HB Pediatric/Adolescent
- Respiratory syncytial virus (RSV) vaccine
- Respiratory syncytial virus vaccine
- Respiratory syncytial virus vaccine, adjuvanted
- Rotarix
- Rotateq
- Rotavirus vaccine, live
- Rubella virus vaccine, live
- Sars-cov-2 (covid-19) vaccine, adenovirus 26 vector (janssen)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (moderna)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (pfizer)
- Sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (moderna)
- Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
- Shingrix
- Smallpox and monkeypox vaccine
- Smallpox monkeypox vaccine, live non-replicating
- Smallpox vaccine
- Spikevax
- Spikevax (2023-2024) PF (cvx 312) 2023-2024
- Tick-borne encephalitis pediatric vaccine
- Tick-borne encephalitis vaccine
- TicoVac
- TicoVac Pediatric
- Vaqta
- Vaqta Pediatric
- Varicella virus (chickenpox) vaccine
- Varicella virus vaccine, live
- Varivax
- Yellow fever vaccine
- YF-Vax
- Zostavax
- Zoster vaccine inactivated
- Zoster vaccine recombinant, adjuvanted
- Zoster vaccine, live
How to use Janssen - Johnson & Johnson COVID-19 Vaccine
Usual Adult Dose for COVID-19:
0.5 mL IM once.
The FDA has issued an EUA for a single booster dose to be given at least 2 months after the primary dose, for people 65 years of age and older, and individuals 18 - 64 years old who are at high risk of severe COVID-19; and individuals 18 - 64 years old whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.
Comments: -This vaccine is not approved by the FDA to prevent COVID-19. The FDA has issued an EUA for the use of this vaccine. -No data is available regarding use of the Janssen COVID-19 Vaccine to complete a coronavirus disease 2019 (COVID-19) vaccine series initiated with another vaccine. Use: Active immunization to prevent COVID-19 disease caused by SARS-CoV-2
Warnings
Some people have had blood clots after receiving this vaccine, but the risk of this side effect is very remote. Becoming infected with COVID-19 is much more dangerous to your health than receiving Janssen COVID-19 Vaccine.
What other drugs will affect Janssen - Johnson & Johnson COVID-19 Vaccine
Before receiving Janssen COVID-19 Vaccine, tell your vaccination provider about all other vaccines you have received and all medicines you use. This includes prescription and over-the-counter medicines, vitamins, and herbal products.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions